Cevaretigene ritoparvovec

DB16798InvestigationalGene Therapies

Cevaretigene ritoparvovec: Overview.

Code names
A001 · AAV2/5-OPTIRPE65 · AAV2/5-RPE65P/OPTIRPE65

Resolves to

Compound
UNIIKVF2UY1OR4CAS2247971-00-0

What you can answer from here — as of April 23, 2025

2Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Cevaretigene ritoparvovec, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In